{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:34:34Z","timestamp":1789554874297,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1002\/jps.22641","type":"journal-article","created":{"date-parts":[[2011,6,7]],"date-time":"2011-06-07T20:25:48Z","timestamp":1307478348000},"page":"3696-3707","source":"Crossref","is-referenced-by-count":34,"title":["Transcriptional Regulation of Organic Anion Transporting Polypeptide SLCO4C1 as a New Therapeutic Modality to Prevent Chronic Kidney Disease"],"prefix":"10.1016","volume":"100","author":[{"given":"Takehiro","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Toyohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutoshi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eikan","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitose","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadayoshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyoshi","family":"Soga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.22641_bb0010","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1152\/physrev.1993.73.4.765","article-title":"Mechanisms mediating renal secretion of organic anions and cations","volume":"73","author":"Pritchard","year":"1993","journal-title":"Physiol Rev"},{"key":"10.1002\/jps.22641_bb0015","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1073\/pnas.0304987101","article-title":"Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney","volume":"101","author":"Mikkaichi","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/jps.22641_bb0020","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1097\/01.ASN.0000022017.96399.B2","article-title":"Roles of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity","volume":"13","author":"Enomoto","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1002\/jps.22641_bb0025","first-page":"3","article-title":"Interactions of human organic anion as well as cation transporters with indoxyl sulfate","volume":"466","author":"Enomoto","year":"2003","journal-title":"Eur J Phramacol."},{"key":"10.1002\/jps.22641_bb0030","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1046\/j.1523-1755.2002.00318.x","article-title":"Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney","volume":"61","author":"Deguch","year":"2002","journal-title":"Kidney Int"},{"key":"10.1002\/jps.22641_bb0035","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1523-1755.2004.00354.x","article-title":"Characterization of uremic toxin transport by organic anion transporters in the kidney","volume":"65","author":"Deguchi","year":"2004","journal-title":"Kidney Int"},{"key":"10.1002\/jps.22641_bb0040","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1681\/ASN.2009070696","article-title":"SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation","volume":"20","author":"Toyohara","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1002\/jps.22641_bb0045","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/hr.2010.113","article-title":"Metabolomic profiling of uremic solutes in CKD patients","volume":"33","author":"Toyohara","year":"2010","journal-title":"Hypertens Res"},{"key":"10.1002\/jps.22641_bb0050","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1002\/jps.22641_bb0055","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/MNH.0b013e328314b6ca","article-title":"Asymmetric dimethylarginine: A novel marker of risk and a potential target for therapy in chronic kidney disease","volume":"17","author":"Zoccali","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1002\/jps.22641_bb0060","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0026-0495(97)90273-0","article-title":"Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency","volume":"46","author":"Marescau","year":"1997","journal-title":"Metabolism"},{"key":"10.1002\/jps.22641_bb0065","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00467-008-0762-9","article-title":"What is new in uremic toxicity","volume":"23","author":"Vanholder","year":"2008","journal-title":"Periatr Nephrol"},{"key":"10.1002\/jps.22641_bb0070","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/sj.ki.5000443","article-title":"Biochemical validation of a rat model for polycystic kidney disease: Comparison of guanidino compound profile with the human condition","volume":"69","author":"Torremans","year":"2006","journal-title":"Kidney Int"},{"key":"10.1002\/jps.22641_bb0075","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1523-1755.2002.00437.x","article-title":"CREED Investigators. Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients","volume":"62","author":"Zoccali","year":"2002","journal-title":"Kidney Int"},{"key":"10.1002\/jps.22641_bb0080","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1681\/ASN.2005020179","article-title":"Asymmetric dimethylarginine and progression of chronic kidney disease: The mild to moderate kidney disease study","volume":"16","author":"Fliser","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1002\/jps.22641_bb0085","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1681\/ASN.V1071606","article-title":"The clinical epidemiology of cardiac disease in chronic renal failure","volume":"10","author":"Parfrey","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1002\/jps.22641_bb0090","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1681\/ASN.V12122759","article-title":"Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis- follow-up of an interventional study","volume":"12","author":"London","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1002\/jps.22641_bb0095","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2133\/dmpk.19.171","article-title":"The organic anion transporter (OATP) family","volume":"19","author":"Mikkaichi","year":"2004","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1002\/jps.22641_bb0100","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00424-003-1168-y","article-title":"Organic anion transporting polypeptides of the OATP-SLC21 family-phylogenetic classification as OATP-SLCO superfamily, new nomenclature and molecular functional properties","volume":"447","author":"Hagenbuch","year":"2004","journal-title":"Pflugers Arch"},{"key":"10.1002\/jps.22641_bb0105","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00424-003-1089-9","article-title":"The SLC22 drug transporter family","volume":"447","author":"Koepsell","year":"2004","journal-title":"Pflugers Arch"},{"key":"10.1002\/jps.22641_bb0110","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11095-006-9181-4","article-title":"Organic anion transporters of the SLC22 family\u2014Biopharmaceutical, physiological, and pathological roles","volume":"24","author":"Rizwan","year":"2007","journal-title":"Pharm Res"},{"key":"10.1002\/jps.22641_bb0115","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1046\/j.1523-1755.2000.00251.x","article-title":"Cellular and molecular aspects of drug transport in the kidney","volume":"58","author":"Inui","year":"2000","journal-title":"Kidney Int"},{"key":"10.1002\/jps.22641_bb0120","doi-asserted-by":"crossref","first-page":"F251","DOI":"10.1152\/ajprenal.00439.2004","article-title":"Molecular physiology of renal organic anion transporters","volume":"290","author":"Sekine","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1002\/jps.22641_bb0125","doi-asserted-by":"crossref","first-page":"F636","DOI":"10.1152\/ajprenal.2001.280.4.F636","article-title":"Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure","volume":"280","author":"Laouari","year":"2001","journal-title":"Am J Physiol Renal Pysiol"},{"key":"10.1002\/jps.22641_bb0130","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1097\/01.ASN.0000143473.64430.AC","article-title":"Contribution of multidrug resistance protein 2 (MRP2\/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter","volume":"15","author":"Smeets","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1002\/jps.22641_bb0135","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1681\/ASN.V133595","article-title":"The MRP4(ABCC4) gene encodes a novel apical organic anion transporter in human kidney proximal tubules\u2014Putative efflux pump for urinary cAMP and cGMP","volume":"13","author":"van Aubel","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1002\/jps.22641_bb0140","doi-asserted-by":"crossref","first-page":"F197","DOI":"10.1152\/ajprenal.2001.281.2.F197","article-title":"The organic anion transporter family\u2014From physiology to ontogeny and the clinic","volume":"281","author":"Sweet","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1002\/jps.22641_bb0145","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1152\/physrev.00040.2003","article-title":"Molecular and cellular physiology of renal organic cation and anion transport","volume":"84","author":"Wright","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1002\/jps.22641_bb0150","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/03602530500205275","article-title":"Function and regulation of multidrug resistance proteins (MRPs) in the renal elimination of organic anions","volume":"37","author":"van de Water","year":"2005","journal-title":"Drug Metab Rev"},{"key":"10.1002\/jps.22641_bb0155","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1254\/jphs.CRJ06006X","article-title":"Organic anion transporter family\u2014Current knowledge","volume":"100","author":"Anzai","year":"2006","journal-title":"J Phramcol Sci"},{"key":"10.1002\/jps.22641_bb0160","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1681\/ASN.V134866","article-title":"Gene expression levels and immunolocalization of organic ion transporters in the human kidney","volume":"13","author":"Motohashi","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1002\/jps.22641_bb0165","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0014-5793(98)00585-7","article-title":"Identification of multispecific organic anion transporter 2 expressed predominantly in the liver","volume":"429","author":"Sekine","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1002\/jps.22641_bb0170","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1124\/jpet.301.3.797","article-title":"Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors","volume":"301","author":"Enomoto","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.22641_bb0175","doi-asserted-by":"crossref","first-page":"13675","DOI":"10.1074\/jbc.274.19.13675","article-title":"Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain","volume":"274","author":"Kusuhara","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1002\/jps.22641_bb0180","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1074\/jbc.275.6.4507","article-title":"Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta","volume":"275","author":"Cha","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1002\/jps.22641_bb0185","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature742","article-title":"Molecular identification of a renal urate\u2013anion exchanger that regulates blood urate levels","volume":"417","author":"Enomoto","year":"2002","journal-title":"Nature"},{"key":"10.1002\/jps.22641_bb0190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1254\/jphs.94.297","article-title":"Human organic anion transporter 4 is a renal apical organic anion\/decarboylate exchanger in the proximal tubules","volume":"94","author":"Ekarantanawong","year":"2004","journal-title":"J Phramacol Sci"},{"key":"10.1002\/jps.22641_bb0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10157-005-0368-5","article-title":"Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease","volume":"9","author":"Enomoto","year":"2005","journal-title":"Clin Exp Nephrol"},{"key":"10.1002\/jps.22641_bb0200","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/BOR.0b013e328032781a","article-title":"New insights into renal transport of urate","volume":"19","author":"Anzai","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1002\/jps.22641_bb0205","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"European Uremic Toxin Work Group (EUTox). Review on uremic toxins\u2014Classification, concentration, and interindividual variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int"},{"key":"10.1002\/jps.22641_bb0210","series-title":"Textbook of nephrology","first-page":"1269","article-title":"Indoxyl sulfate","author":"Niwa","year":"2001"},{"key":"10.1002\/jps.22641_bb0215","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.jrn.2010.05.002","article-title":"Indoxyl sulfate is a nephrovascular toxin","volume":"20","author":"Niwa","year":"2010","journal-title":"J Ren Nutr"},{"key":"10.1002\/jps.22641_bb0220","first-page":"96","article-title":"Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis","volume":"124","author":"Niwa","year":"1994","journal-title":"J Lab Clin Med"},{"key":"10.1002\/jps.22641_bb0225","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/ndt\/15.11.1773","article-title":"An oral sorbent reduces overload of indoxyl sulfate and gene expression of TGF-\u03b21 in ureic rat kidneys","volume":"15","author":"Miyazaki","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1002\/jps.22641_bb0230","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1111\/j.1744-9987.2007.00515.x","article-title":"Roles of organic anion transporters in the progression of chronic renal failure","volume":"11","author":"Enomoto","year":"2007","journal-title":"Therapeu Apheresis Dial"},{"key":"10.1002\/jps.22641_bb0235","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1124\/jpet.105.085613","article-title":"Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats","volume":"14","author":"Deguchi","year":"2005","journal-title":"J Pharamacol Exp Ther"},{"key":"10.1002\/jps.22641_bb0240","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.ki.5002104","article-title":"Down regulation of organic anion transporters in rat kidney under ischemia reperfusion -induced acute renal failure","volume":"71","author":"Matsuzaki","year":"2007","journal-title":"Kidney Int"},{"key":"10.1002\/jps.22641_bb0245","doi-asserted-by":"crossref","first-page":"F1599","DOI":"10.1152\/ajprenal.00473.2006","article-title":"Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats","volume":"292","author":"Schneider","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1002\/jps.22641_bb0250","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1007\/s11095-008-9668-2","article-title":"Regulation of renal organic ion transporters in cisplatin-induced acute kidney injury and uremia in rats","volume":"25","author":"Morisaki","year":"2008","journal-title":"Pharm Res"},{"key":"10.1002\/jps.22641_bb0255","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.tox.2008.06.009","article-title":"Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment","volume":"250","author":"Aleksunes","year":"2008","journal-title":"Toxicology"},{"key":"10.1002\/jps.22641_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2005.05.010","article-title":"Effects of renal failure on drug transport and metabolism","volume":"109","author":"Sun","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1002\/jps.22641_bb0265","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pharmthera.2009.09.008","article-title":"Pathophysiological regulation of renal SLC22A organic ion transporters in acute kidney injury\u2014Pharmacological and toxicological implications","volume":"125","author":"Saito","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1002\/jps.22641_bb0270","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/B:PHAM.0000012153.71993.cb","article-title":"Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases","volume":"21","author":"Sakurai","year":"2004","journal-title":"Pharm Res"},{"key":"10.1002\/jps.22641_bb0275","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1007\/s11095-005-8383-5","article-title":"Pharmacokinetic siginificance of renal OAT3(SLC22A8) for anionic drug elimination in patients with mesangial proliferative glomerulonephritis","volume":"22","author":"Sakurai","year":"2005","journal-title":"Pharm Res"},{"key":"10.1002\/jps.22641_bb0280","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1074\/jbc.M508050200","article-title":"Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice","volume":"281","author":"Eraly","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1002\/jps.22641_bb0285","doi-asserted-by":"crossref","first-page":"26934","DOI":"10.1074\/jbc.M203803200","article-title":"Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice","volume":"277","author":"Sweet","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1002\/jps.22641_bb0290","doi-asserted-by":"crossref","first-page":"F1332","DOI":"10.1152\/ajprenal.00319.2007","article-title":"Organic anion transporter 3 (Oat3,Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G","volume":"293","author":"Vanwert","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1002\/jps.22641_bb0295","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11095-007-9407-0","article-title":"Impaired clearance of methotrexate in organic anion transporter 3 (Slc22a8) knockout mice\u2014A gender specific impact of reduced folates","volume":"25","author":"VanWert","year":"2008","journal-title":"Pharm Res"},{"key":"10.1002\/jps.22641_bb0300","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12311-008-0029-9","article-title":"Thyroid hormone transporters in the brain","volume":"7","author":"Suzuki","year":"2008","journal-title":"Cereberum"},{"key":"10.1002\/jps.22641_bb0305","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1043-2760(02)00599-4","article-title":"Thyroid hormone transporters: Recent advances","volume":"13","author":"Abe","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"10.1002\/jps.22641_bb0310","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00467-008-1046-0","article-title":"Inflammation in chronic kidney disease: Role in the progression of renal and cardiovascular disease","volume":"24","author":"Silverstein","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1002\/jps.22641_bb0315","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1526-0968.2004.00137.x","article-title":"Protective effect of an oral adsorbent on renal function in chronic renal failure: Determinants of its efficacy in diabetic nephropathy","volume":"8","author":"Sanaka","year":"2004","journal-title":"Ther Apher Dial"},{"key":"10.1002\/jps.22641_bb0320","first-page":"S188","article-title":"Effects of oral adsorbent AST-120 on the progression of chronic renal failure: A randomized controlled study","volume":"63","author":"Owada","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"10.1002\/jps.22641_bb0325","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/pr034020m","article-title":"Quantitative metabolome analysis using capillary electrophoresis mass spectrometry","volume":"2","author":"Soga","year":"2003","journal-title":"J Proteome Res"},{"key":"10.1002\/jps.22641_bb0330","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10157-007-0471-x","article-title":"Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease","volume":"11","author":"Ueda","year":"2007","journal-title":"Clin Exp Nephrol"},{"key":"10.1002\/jps.22641_bb0335","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/MNH.0b013e328314b6ca","article-title":"Asymmetric dimethylarginine: A novel marker of risk and a potential target for therapy in chronic kidney disease","volume":"17","author":"Kielstein","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1002\/jps.22641_bb0340","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/ndt\/gfm793","article-title":"Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status","volume":"23","author":"Taes","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1002\/jps.22641_bb0345","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1525-139X.2009.00577.x","article-title":"Guanidino compounds as uremic (neuro) toxins","volume":"22","author":"De Deyn","year":"2009","journal-title":"Semin Dial"},{"key":"10.1002\/jps.22641_bb0350","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0021-9258(19)51244-3","article-title":"Inhibition of aconitase by trans-aconitate","volume":"180","author":"Saffran","year":"1949","journal-title":"J Biol Chem"},{"key":"10.1002\/jps.22641_bb0355","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbrc.2005.08.162","article-title":"Molecular mechanism of AhR functions in the regulation of cytochrome P450 genes","volume":"228","author":"Fujii-Kuriyama","year":"2005","journal-title":"Biophys Res Commun"},{"key":"10.1002\/jps.22641_bb0360","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/nar\/21.1.119","article-title":"Mechanism of dioxin action: Receptor\u2013enhancer interactions in intact cells","volume":"21","author":"Wu","year":"1993","journal-title":"Nucleic Acids Res"},{"key":"10.1002\/jps.22641_bb0365","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mrfmmm.2004.05.023","article-title":"Contribution of NAD(P)H: Quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors","volume":"555","author":"Nioi","year":"2004","journal-title":"Mutat Res"},{"key":"10.1002\/jps.22641_bb0370","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.pharmtox.43.100901.135828","article-title":"Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals","volume":"43","author":"Denison","year":"2003","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915319729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915319729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T19:21:42Z","timestamp":1637781702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915319729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":73,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0022354915319729"],"URL":"https:\/\/doi.org\/10.1002\/jps.22641","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}